Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.1450
0.00 (0.00%)
At close: Feb 6, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 9.81 million as of February 9, 2026. Its market cap has decreased by -42.23% in one year.
Market Cap
9.81M
Enterprise Value
10.84M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has increased from 5.25M to 9.81M, an increase of 86.94%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 9.81M | -3.33% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Britannia Life Sciences | 16.23M |
| PreveCeutical Medical | 14.95M |
| Innovotech | 14.04M |
| Lobe Sciences | 13.47M |
| Pharmala Biotech Holdings | 10.89M |
| Glow Lifetech | 9.98M |
| COSCIENS Biopharma | 8.72M |
| Marvel Biosciences | 8.12M |